Thrombopoietin signalling is important in healthy blood cell development due to its roles in platelet production and maintenance of haematopoietic stem cells, and mutations in the receptor or associated regulators of the pathway manifest clinically as thrombocytopenia or myeloproliferative disease. The gene discussed is THPO; the disease is myeloproliferative disorder.